Walk Ahead for a Brain Tumor Cure on Oct. 21
Thousands expected at annual event
Event Information (passed)
The ninth annual Walk Ahead for a Brain Tumor Cure is Sunday, Oct. 21, 2018 at Sawyer Point.
- Registration begins at 7:30 a.m.
- Timed 5K run begins at 8:30 a.m.
- 5K walk begins at 9 a.m.
- Wheelchair friendly 2K begins at 9 a.m.
Thousands of walkers and runners will support research and educational efforts of the University of Cincinnati Brain Tumor Center at the University of Cincinnati Gardner Neuroscience Institute.
Now nearly a decade in existence, Walk Ahead 2018 will have raised $2 million over its entire lifetime, following the 2018 event.
Brain tumors are not uncommon. More than 200,000 people are stricken with brain tumors in America every year. During the last two decades, the frequency of brain tumors has increased 22 percent overall and 55 percent in people over 65 years of age. The University of Cincinnati Brain Tumor Center is a regional destination for brain tumor patients, providing compassionate care while striving to find causes and cures. The funds raised through Walk Ahead advance the innovative research necessary to developing new treatments.
Related Stories
High Court offers protections for therapy speech
April 5, 2026
Jennifer Bard, a professor in the Donald P. Klekamp College of Law and the UC Department of Internal Medicine, spoke with journalists about the US Supreme Court ruling granting first amendment protections for speech offered during therapy sessions.
UC names Suzanne Judd, PhD, as inaugural director of new Center for Public Health
April 2, 2026
Following an extensive national search, the University of Cincinnati College of Medicine has appointed Suzanne E. Judd, PhD, as the inaugural director of its newly established Center for Public Health. Judd, a renowned epidemiologist and interdisciplinary scholar, will lead the center’s mission to transform community health through innovative research, education and strategic advocacy.
Could GLP-1s help curb the opioid crisis?
April 1, 2026
The University of Cincinnati's John Winhusen was featured in a Rolling Stone article discussing the potential for GLP-1s to treat substance abuse disorders.